Default: Experimental Hematology

ISSN: 0301-472X

Journal Home

Journal Guideline

Experimental Hematology Q1 Unclaimed

Elsevier Inc. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Experimental Hematology is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 117. It has an SJR impact factor of 1,302 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Experimental Hematology

1,302

SJR Impact factor

117

H Index

88

Total Docs (Last Year)

332

Total Docs (3 years)

3869

Total Refs

828

Total Cites (3 years)

323

Citable Docs (3 years)

2,7

Cites/Doc (2 years)

43,97

Ref/Doc


Best articles

A candidate cytokine gene selectively expressed in human CD34 + cells

View more

A new method for identification of adhesive interactions under shear force conditions

View more

A novel minimized fixed-bed cultivation system for hematopoietic cells

View more

All-trans-retinoic acid inhibits the erythroid differentiation program of human marrow CD34+ progenitors

View more

Allelic loss in hla class i expression is not a common event in acute leukemia

View more

Antiproliferative signaling of the cytokine receptor CD30 in the anaplastic large cell lymphoma cell line karpas 299

View more

Ascorbic acid protects from activation of multiple caspases and of cytochrome c release induced by oxidative stress in human leukemia cells

View more

Cml patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro

View more

Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells

View more

Cytokine treatment of hematopoietic stem/progenitor cells induces a homing defect in nonmyeloablated hosts

View more

Does endogenous FLT3-ligand reflect impaired hematopoiesis in patients with b-lymphocytic chronic leukemia?

View more

Ebv-specific t-cell lines for adoptive transfer to pmrd allograft recipients

View more
SHOW MORE ARTICLES

Effect of activated adherent cell conditioned medium on human CD34+ cell recruitment in short- and long term cultures

View more

Effect of combined INTERLEUKIN-1-alpha (IL1-A), Cyclophosphamide (Ctx) Treatment on hematopoietic stem cell function and numbers

View more

Effect of cryopreservation on adhesion molecule expression in peripheral blood derived CD34+ cells

View more

Effects of anti-oxidants on normal and leukemic hematopoiesis

View more

Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients A pilot study

View more

Endostatin induces tumor stabilization after chemo- or ANTI-CD20 therapy of high-grade non-hodgkin's lymphoma (Nhl)

View more

Enhanced ability of myelopoietins, dual receptor agonists for human IL-3 and g-csf receptors and the IL-3 receptor agonist, daniplestim, to suppress apoptosis and stimulate cytokine-inducible gene expression

View more

Epitope spreading occurs in cancer patients after vaccination with a single tumor antigen

View more

Ex vivo expansion of cord blood megakaryocytic cells

View more

Expression of CD41 on CD34+ primitive yolk sac hematopoietic progenitors

View more

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukemia in patients over 60 years of age

View more

Fetal liver hematopoietic stem cells

View more

Comments

No comments ... Be the first to comment!